IRNA Reports on the Complex Realities of Iran’s Pharmaceutical System
In a recent in-depth report, IRNA News Agency shed light on the ongoing challenges within Iran’s pharmaceutical sector, especially concerning rare diseases and unlisted medications.
A striking excerpt from the report reads:
“The drug exists — but it’s not on the list!”
This may be the most accurate way to describe the condition of patients with rare diseases, whose prescriptions often include medications that are not officially registered in Iran’s national pharmaceutical system.
These so-called “single-prescription drugs” form a critical yet highly complicated link in the treatment chain. They are often prescribed to ensure survival or reduce severe pain — yet their journey to the patient is riddled with administrative, financial, and legal barriers.
